3A,7A-DI-EPI-PERINDOPRIL, (3AR,7AR)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H32N2O5
Molecular Weight	368.4678
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of 3A,7A-DI-EPI-PERINDOPRIL, (3AR,7AR)-

Structure Search

SMILES

CCC[C@H](N[C@@H](C)C(=O)N1[C@@H]2CCCC[C@@H]2C[C@H]1C(O)=O)C(=O)OCC

InChI

InChIKey=IPVQLZZIHOAWMC-NPJQDHAYSA-N

InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14-,15+,16-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H32N2O5
Molecular Weight	368.4678
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697

(±)-3A,7A-di-epi-Perindopril is a mixture of two isomers (S, RR, SS) and (R, SS, RR) each of which is an isomer of the antihypertensive drug perindopril. The first of which has the same activity as the compound while the second one is almost inactive.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Angiotensin-converting enzyme 94 Target ID: CHEMBL1808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697	Inhibitor 8504

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596
Unknown 2596

Sample Use Guides

In Vivo Use Guide

dog: 1 mg/kg

Route of Administration: Other

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:24:02 GMT 2025` Edited by `admin` on `Mon Mar 31 23:24:02 GMT 2025`
Record UNII	HYT0OR3WXJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

3A,7A-DI-EPI-PERINDOPRIL, (3AR,7AR)-

Common Name

English

1H-INDOLE-2-CARBOXYLIC ACID, 1-(2-((1-(ETHOXYCARBONYL)BUTYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-, (2S-(1(R*(R*)),2.ALPHA.,3A.ALPHA.,7A.ALPHA.))-

Preferred Name

English

Code System Code Type Description

PUBCHEM

6102289

Created by admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025

PRIMARY

CAS

145513-32-2

Created by admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025

PRIMARY

FDA UNII

HYT0OR3WXJ

Created by admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025

PRIMARY

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697

Approval Year

Targets

Conditions

Sample Use Guides

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697